$CLRC
ClimateRock

2022 Q2 Form 10-Q Financial Statement

#000121390022046917 Filed on August 11, 2022

View on sec.gov

Income Statement

Concept 2022 Q2 2022 Q1 2021 Q4
Revenue $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $271.7K $1.200K
YoY Change
Operating Profit -$271.7K -$1.200K -$4.730K
YoY Change
Interest Expense $86.73K
YoY Change
% of Operating Profit
Other Income/Expense, Net $86.73K
YoY Change
Pretax Income -$184.9K -$1.200K
YoY Change
Income Tax
% Of Pretax Income
Net Earnings -$184.9K -$1.200K -$4.730K
YoY Change
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share -$18.56K -$120.50
COMMON SHARES
Basic Shares Outstanding 1.875M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2022 Q2 2022 Q1 2021 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $80.32M $4.950K
YoY Change
Cash & Equivalents $299.4K $4.950K
Short-Term Investments $80.02M
Other Short-Term Assets $276.3K $232.6K
YoY Change
Inventory
Prepaid Expenses $276.3K
Receivables
Other Receivables
Total Short-Term Assets $80.59M $237.5K $83.34K
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $0.00 $0.00 $0.00
YoY Change
TOTAL ASSETS
Total Short-Term Assets $80.59M $237.5K $83.34K
Total Long-Term Assets $0.00 $0.00 $0.00
Total Assets $80.59M $237.5K $83.34K
YoY Change
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses $32.29K $26.23K
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $192.2K
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $2.395M $218.4K $63.07K
YoY Change
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $2.395M $218.4K $63.07K
Total Long-Term Liabilities $0.00 $0.00
Total Liabilities $2.395M $218.4K $63.07K
YoY Change
SHAREHOLDERS EQUITY
Retained Earnings -$1.819M -$4.730K
YoY Change
Common Stock $12.00 $0.00 $0.00
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares 946.2K shares
Shareholders Equity -$1.819M $19.07K $20.27K
YoY Change
Total Liabilities & Shareholders Equity $80.59M $237.5K $83.34K
YoY Change

Cashflow Statement

Concept 2022 Q2 2022 Q1 2021 Q4
OPERATING ACTIVITIES
Net Income -$184.9K -$1.200K -$4.730K
YoY Change
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$516.7K -$200.00
YoY Change
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities -$79.93M
YoY Change
Cash From Investing Activities -$79.93M
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 80.74M 5.150K
YoY Change
NET CHANGE
Cash From Operating Activities -516.7K -200.0
Cash From Investing Activities -79.93M
Cash From Financing Activities 80.74M 5.150K
Net Change In Cash 294.5K 4.950K $0.00
YoY Change
FREE CASH FLOW
Cash From Operating Activities -$516.7K -$200.00
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Local Phone Number
LocalPhoneNumber
203 954 0590
dei Security12b Title
Security12bTitle
Class A Ordinary Share, par value $0.0001 per share
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2022-06-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-41363
dei Entity Registrant Name
EntityRegistrantName
CLIMATEROCK
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
E9
dei Entity Address Address Line1
EntityAddressAddressLine1
50 Sloane Avenue
dei Entity Address City Or Town
EntityAddressCityOrTown
London
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
SW3 3DD
dei Entity Address Country
EntityAddressCountry
GB
dei City Area Code
CityAreaCode
+44
dei Trading Symbol
TradingSymbol
CLCR
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
No
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
dei Entity Shell Company
EntityShellCompany
true
CY2022Q2 us-gaap Cash
Cash
299401 usd
CY2022Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
276278 usd
CY2021Q4 us-gaap Deferred Offering Costs
DeferredOfferingCosts
83343 usd
CY2022Q2 us-gaap Assets Held In Trust Current
AssetsHeldInTrustCurrent
80017979 usd
CY2022Q2 us-gaap Assets Current
AssetsCurrent
80593658 usd
CY2021Q4 us-gaap Assets Current
AssetsCurrent
83343 usd
CY2022Q2 us-gaap Assets
Assets
80593658 usd
CY2021Q4 us-gaap Assets
Assets
83343 usd
CY2022Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
32289 usd
CY2021Q4 us-gaap Loans Payable Current
LoansPayableCurrent
63073 usd
CY2022Q2 us-gaap Deferred Compensation Liability Current
DeferredCompensationLiabilityCurrent
2362500 usd
CY2022Q2 us-gaap Liabilities Current
LiabilitiesCurrent
2394789 usd
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
63073 usd
CY2022Q2 us-gaap Liabilities
Liabilities
2394789 usd
CY2021Q4 us-gaap Liabilities
Liabilities
63073 usd
CY2022Q2 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
80017979 usd
CY2022Q2 us-gaap Common Stock Value
CommonStockValue
12 usd
CY2022Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
24784 usd
CY2022Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1819319 usd
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-4730 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
-1819110 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
20270 usd
CY2022Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
80593658 usd
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
83343 usd
CY2022Q2 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
271669 usd
us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
272869 usd
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-271669 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-272869 usd
CY2022Q2 us-gaap Interest Income Securities Other Us Government
InterestIncomeSecuritiesOtherUSGovernment
86729 usd
us-gaap Interest Income Securities Other Us Government
InterestIncomeSecuritiesOtherUSGovernment
86729 usd
CY2022Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
86729 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
86729 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-184940 usd
us-gaap Net Income Loss
NetIncomeLoss
-186140 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
20270 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-1200 usd
CY2022Q2 us-gaap Stock Issued During Period Shares Share Based Compensation Forfeited
StockIssuedDuringPeriodSharesShareBasedCompensationForfeited
187500 shares
CY2022Q2 clcr Sale Of Unit
SaleOfUnit
7875000 shares
CY2022Q2 clcr Sale Of Per Unit
SaleOfPerUnit
10
CY2022Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
73656058 usd
CY2022Q2 clcr Issuance Of Underwriter Units
IssuanceOfUnderwriterUnits
118125 shares
CY2022Q2 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
946181 usd
CY2022Q2 clcr Sale Of Warrants
SaleOfWarrants
3762500 usd
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
3762500 usd
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
-80017979 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-184940 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
-1819110 usd
us-gaap Net Income Loss
NetIncomeLoss
-186140 usd
us-gaap Gain Loss On Investments
GainLossOnInvestments
86729 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
32289 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
276278 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-516858 usd
us-gaap Payments To Acquire Assets Investing Activities
PaymentsToAcquireAssetsInvestingActivities
79931250 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-79931250 usd
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
5150 usd
us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
217641 usd
us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
78750000 usd
us-gaap Payments For Repurchase Of Initial Public Offering
PaymentsForRepurchaseOfInitialPublicOffering
1552500 usd
us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
3762500 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
80747509 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
299401 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
299401 usd
clcr Deferred Offering Costs Paid By Related Party
DeferredOfferingCostsPaidByRelatedParty
149418 usd
clcr Deferred Underwriting Commission Charged To Additional Paid In Capital
DeferredUnderwritingCommissionChargedToAdditionalPaidInCapital
2362500 usd
clcr Allocation Of Offering Costs To Class A Ordinary Shares Subject To Redemption
AllocationOfOfferingCostsToClassAOrdinarySharesSubjectToRedemption
304011 usd
clcr Issuance Of Representative Shares
IssuanceOfRepresentativeShares
946181 usd
clcr Initial Value Of Public Shares Subject To Possible Redemptionin Shares
InitialValueOfPublicSharesSubjectToPossibleRedemptioninShares
71851500 usd
clcr Reclassification Of Offering Costs Related To Public Shares
ReclassificationOfOfferingCostsRelatedToPublicShares
-4647702 usd
clcr Remeasurement Adjustment On Public Shares Subject To Possible Redemption
RemeasurementAdjustmentOnPublicSharesSubjectToPossibleRedemption
12814181 usd
us-gaap Payments For Underwriting Expense
PaymentsForUnderwritingExpense
1181250 usd
us-gaap Payments For Commissions
PaymentsForCommissions
2362500 usd
CY2022Q2 us-gaap Treasury Stock Shares
TreasuryStockShares
946169 shares
us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
604011 usd
us-gaap Sale Of Stock Consideration Received On Transaction
SaleOfStockConsiderationReceivedOnTransaction
79931250 usd
us-gaap Cash Acquired From Acquisition
CashAcquiredFromAcquisition
299401 usd
CY2022Q2 clcr Assets Held In Trust Account
AssetsHeldInTrustAccount
0.80 pure
CY2022Q2 clcr Interest Earned On The Funds Held In The Trust Account
InterestEarnedOnTheFundsHeldInTheTrustAccount
10.15
CY2022Q2 us-gaap Deposits
Deposits
787500 usd
CY2022Q2 clcr Deposits Per Share
DepositsPerShare
0.1
CY2022Q2 us-gaap Cash
Cash
299401 usd
CY2022Q2 clcr Working Capital Deficit
WorkingCapitalDeficit
543390 usd
CY2022Q2 us-gaap Investments And Cash
InvestmentsAndCash
299401 usd
CY2021Q4 us-gaap Investments And Cash
InvestmentsAndCash
0 usd
CY2022Q2 us-gaap Assets Held In Trust
AssetsHeldInTrust
79931250 usd
us-gaap Debt Instrument Term
DebtInstrumentTerm
P185D
CY2022Q2 us-gaap Assets Held In Trust Noncurrent
AssetsHeldInTrustNoncurrent
80017979 usd
us-gaap Interest Income Securities Other Us Government
InterestIncomeSecuritiesOtherUSGovernment
86729 usd
us-gaap Use Of Estimates
UseOfEstimates
<p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Use of estimates</b></p><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b> </b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Accordingly, the actual results could differ significantly from those estimates.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><b> </b></p>
CY2021Q4 us-gaap Deferred Offering Costs
DeferredOfferingCosts
83343 usd
CY2022Q2 us-gaap Employee Stock Ownership Plan Esop Fair Value Of Shares Subject To Repurchase Obligation
EmployeeStockOwnershipPlanESOPFairValueOfSharesSubjectToRepurchaseObligation
4647702 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-184940 usd
us-gaap Net Income Loss
NetIncomeLoss
-186140 usd
CY2022Q2 us-gaap Temporary Equity Accretion To Redemption Value
TemporaryEquityAccretionToRedemptionValue
12727452 usd
us-gaap Temporary Equity Accretion To Redemption Value
TemporaryEquityAccretionToRedemptionValue
12727452 usd
CY2022Q2 us-gaap Temporary Equity Net Income
TemporaryEquityNetIncome
-12912392 usd
us-gaap Temporary Equity Net Income
TemporaryEquityNetIncome
-12913592 usd
CY2022Q2 us-gaap Temporary Equity Accretion To Redemption Value Adjustment
TemporaryEquityAccretionToRedemptionValueAdjustment
86729 usd
us-gaap Temporary Equity Accretion To Redemption Value Adjustment
TemporaryEquityAccretionToRedemptionValueAdjustment
86729 usd
CY2022Q2 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-12999121 usd
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-13000321 usd
CY2022Q2 us-gaap Sale Of Stock Price Per Share
SaleOfStockPricePerShare
10
CY2022Q2 us-gaap Sale Leaseback Transaction Gross Proceeds Investing Activities
SaleLeasebackTransactionGrossProceedsInvestingActivities
78750000 usd
clcr Gross Proceeds
GrossProceeds
78750000 usd
clcr Proceeds Allocated To Public Warrants And Public Rights
ProceedsAllocatedToPublicWarrantsAndPublicRights
6898500 usd
us-gaap Partners Capital Account Public Sale Of Units Net Of Offering Costs
PartnersCapitalAccountPublicSaleOfUnitsNetOfOfferingCosts
4647702 usd
clcr Accretion Of Carrying Value To Redemption Value
AccretionOfCarryingValueToRedemptionValue
12814181 usd
clcr Ordinary Shares Subject To Possible Redemption
OrdinarySharesSubjectToPossibleRedemption
80017979 usd
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
375000 shares
clcr Founder Shares Were No Longer Subject To Forfeiture
FounderSharesWereNoLongerSubjectToForfeiture
93750 shares
clcr Subject To Forfeiture Shares
SubjectToForfeitureShares
187500 shares
us-gaap Sale Of Stock Number Of Shares Issued In Transaction
SaleOfStockNumberOfSharesIssuedInTransaction
1968750 shares
us-gaap Stock Issued During Period Shares Purchase Of Assets
StockIssuedDuringPeriodSharesPurchaseOfAssets
1968750 shares
CY2022Q2 us-gaap Sponsor Fees
SponsorFees
10000 usd
CY2022Q2 us-gaap Accrued Utilities Current
AccruedUtilitiesCurrent
10000 usd
us-gaap Travel And Entertainment Expense
TravelAndEntertainmentExpense
5000 usd
CY2021Q4 us-gaap Partners Capital Account Units Treasury
PartnersCapitalAccountUnitsTreasury
1125000 shares
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised
375000 shares
us-gaap Long Term Purchase Commitment Description
LongTermPurchaseCommitmentDescription
The underwriters were entitled to an underwriting discount of $0.45 per unit, or $3,543,750 in the aggregate, of which $0.15 per unit, or $1,181,250 was paid upon the closing of the Initial Public Offering. Of the $0.45 discount, the underwriters were entitled to a deferred underwriting commission of  $0.30 per unit, or $2,362,500 in the aggregate.
us-gaap Litigation Settlement Expense
LitigationSettlementExpense
125000 usd
CY2022Q2 us-gaap Litigation Settlement Expense
LitigationSettlementExpense
125000 usd
CY2022Q2 us-gaap Servicing Liability At Fair Value Amount
ServicingLiabilityAtFairValueAmount
946181 usd
CY2022Q2 us-gaap Excess Stock Shares Outstanding
ExcessStockSharesOutstanding
118125 shares
clcr Warrants Redemption Description
WarrantsRedemptionDescription
●in whole and not in part; ●at a price of  $0.01 per warrant;   ●upon a minimum of 30 days’ prior written notice of redemption; and  ●if, and only if, the last reported last sale price of the ordinary shares equals or exceeds $18.00 per share for any 20 trading days within a 30-trading day period ending on the third trading day prior to the date on which the Company sends the notice of redemption to the warrant holders.
clcr Equity Linked Securities Description
EquityLinkedSecuritiesDescription
If: (i) the Company issues additional ordinary shares or securities convertible into or exercisable or exchangeable for shares of ordinary shares for capital raising purposes in connection with the closing of its initial Business Combination at an issue price or effective issue price of less than $9.20 per ordinary shares, with such issue price or effective issue price to be determined in good faith by the Board (and in the case of any such issuance to the Sponsor or its affiliates, without taking into account any founder shares held by such holder or affiliates, as applicable, prior to such issuance) (the “New Issuance Price”); (ii) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of the initial Business Combination on the date of the consummation thereof (net of redemptions); and (iii) the volume weighted average trading price of the ordinary shares during the 20 trading day period starting on the trading day prior to the day on which the Company consummates the initial Business Combination (such price, the “Market Value”) is below $9.20 per share, the Warrant Price shall be adjusted (to the nearest cent) to be equal to 115% of the greater of the Market Value and the New Issuance Price and the Redemption Trigger Price ($18.00) shall be adjusted to equal to 180% of the greater of the Market Value and the Newly Issued Price. 
CY2021Q4 us-gaap Cash
Cash
usd
CY2022Q2 us-gaap Loans Payable Current
LoansPayableCurrent
usd
CY2021Q4 us-gaap Deferred Compensation Liability Current
DeferredCompensationLiabilityCurrent
usd
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2021Q4 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
usd
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Entity Central Index Key
EntityCentralIndexKey
0001903392

Files In Submission

Name View Source Status
0001213900-22-046917-index-headers.html Edgar Link pending
0001213900-22-046917-index.html Edgar Link pending
0001213900-22-046917.txt Edgar Link pending
0001213900-22-046917-xbrl.zip Edgar Link pending
clcr-20220630.xsd Edgar Link pending
clcr-20220630_cal.xml Edgar Link unprocessable
clcr-20220630_def.xml Edgar Link unprocessable
clcr-20220630_pre.xml Edgar Link unprocessable
clcr-20220630_lab.xml Edgar Link unprocessable
f10q0622ex31-1_climaterock.htm Edgar Link pending
f10q0622ex31-2_climaterock.htm Edgar Link pending
f10q0622ex32-1_climaterock.htm Edgar Link pending
f10q0622ex32-2_climaterock.htm Edgar Link pending
f10q0622_climaterock.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
f10q0622_climaterock_htm.xml Edgar Link completed
FilingSummary.xml Edgar Link unprocessable